SAN FRANCISCO, June 12, 2018 /PRNewswire/ -- San Francisco medtech innovation company TheraNova, LLC, and UCSF Surgical Innovations, an incubator-accelerator for University of California, San Francisco (UCSF) medtech innovators, have announced a partnership that aims to co-develop device technologies
Surgical Innovations is a five-year-old initiative of UCSF's Departments of Surgery and Bioengineering & Therapeutic Sciences designed to drive early-stage device technologies toward clinical use. The program has advanced eight novel devices to first-in-human trials and attracted over $30 million in grants and seed-stage investments.
"As a major source of medtech innovation in San Francisco, UCSF has an unparalleled environment for device invention at the doorstep of Silicon Valley. We have world-class clinical KOLs, state-of-the-art research facilities, leading translational bioengineers and passionate trainees working at the frontier of patient care," says Hanmin Lee, MD, surgeon-in-chief of UCSF Benioff Children's Hospital and Surgical Innovations' clinical lead.
Located blocks from UCSF's campus, TheraNova has been committed to developing innovative solutions addressing large unmet needs and bringing them to market with in-house capabilities including R&D, clinical, regulatory, quality, intellectual property and business development. Since 2006, TheraNova has created 14 spin-off companies that have raised over $280 million in venture funding.
TheraNova CEO Dan Burnett, MD, has long advised projects and collaborated with programs at UCSF. "As Industry Director of the UC Berkeley-UCSF Master of Translational Medicine program I have been impressed with the caliber of both the students and the faculty. With this official partnership with Surgical Innovations, we are hoping to work more closely with UCSF innovators to bring more impactful products to market," says Burnett.
"UCSF has a long history of collaborating with external partners to translate our research into actual products," says UCSF professor of bioengineering Shuvo Roy, PhD. "TheraNova has resources in every step of the device development process, and we look forward to utilizing their expertise and working together to accelerate groundbreaking innovation to patients."
Contact:Rebecca Lin 1-650-9315958 firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/theranova-and-ucsf-surgical-innovations-announce-partnership-to-accelerate-medtech-innovation-300665284.html
SOURCE TheraNova, LLC
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All